homeostasis/metabolism
• tamoxifen-treated mice treated with an intratracheal instillation of bleomycin to induce lung injury show reduced severity of pulmonary fibrosis, lower lung inflammation and induction of TNF-alpha and TGF-beta expression, improved weight gain after the initial loss, reduced apoptotic cells, inhibited lipofibroblast-to-myofibroblast transdifferentiation, and enhanced alveolar type 2 cell proliferation and differentiation into alveolar type 1, enhancing alveolar repair
|
immune system
• tamoxifen-treated mice intratracheally installed with bleomycin show lower lung inflammation and fibrosis and lower induction of TNF-alpha and TGF-beta expression indicating amelioration of bleomycin-induced pulmonary inflammation
|
respiratory system
• tamoxifen-treated mice with bleomycin-induced lung injury show enhanced alveolar type 2 cell proliferation and enhanced alveolar type 2 to alveolar type 1 differentiation, enhancing alveolar repair
|
cellular
• tamoxifen-treated mice with bleomycin-induced lung injury show a reduction in apoptotic cells
|
• lipofibroblast-to-myofibroblast transdifferentiation in the lungs is inhibited in tamoxifen-treated mice with bleomycin-induced lung fibrosis
|